Congleton Jon
Chief Executive Officer
1 company
Insider Signal Score
47
AverageTrades Analyzed
18
12M Win Rate
7.1%
Avg 3M Return
-3.3%
Avg 12M Return
-23.6%
Congleton Jon is a Chief Executive Officer at Mineralys Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 3 sells.
Estimated insider holdings value: $18.1M based on current market prices.
Holdings by Company
MLYSApr 13, 2026
Current Shares689.3K
Value$18.11M
Net Activity-438,979
Bought: 10.8KSold: 449.7K
Transaction History
Showing 5 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Sell | 72,797 | $12.70 | $924,203.22 | -2.4% | -7.9% | +13.8% | |
| Nov 22, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 4,250 | $5.97 | $25,355.93 | +0.4% | +156.7% | +99.2% | |
| Sep 6, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 2,250 | $12.08 | $27,180.00 | +0.2% | -43.9% | -1.5% | |
| Aug 17, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 2,250 | $12.10 | $27,225.00 | +0.2% | -44.3% | -19.5% | |
| Aug 11, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 2,000 | $12.89 | $25,780.00 | +0.2% | -42.2% | -14.0% |
← PrevPage 2